Navigation Links
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Date:3/6/2009

All amounts are in US dollars

QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement with sanofi-aventis (EURONEXT: SAN; NYSE: SNY) for the development, registration and marketing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market. Cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, is currently in a Phase 3 program in BPH, a non-cancerous enlargement of the prostate, affecting more than 20 million men in the U.S. alone.

Under the terms of the agreement, sanofi-aventis will make an initial $30 million upfront payment to AEterna Zentaris which will also be entitled to receive up to $135 million in additional payments upon achieving certain pre-established regulatory and commercial milestones. Furthermore, AEterna Zentaris will be entitled to receive escalating double-digit royalties on future net sales of cetrorelix for BPH in the United States. Sanofi-aventis will be responsible for the commercialization and booking of sales in the U.S.; however, AEterna Zentaris has retained certain rights to co-promote cetrorelix for BPH in the U.S. market. Finally, sanofi-aventis may perform future Phase 3b and Phase 4 clinical trials, while AEterna Zentaris will have free access to all data for other territories.

"We are delighted to have a partner such as sanofi-aventis who has a proven track record in urology. This partnership marks an important milestone in our quest to bring cetrorelix to market which could provide millions of men with a novel treatment for BPH. Furthermore, this compound could generate sign
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. AEterna Zentaris to Present at Upcoming RBC Capital Markets Healthcare Conference
2. AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
3. AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
4. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
5. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
6. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
7. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
8. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
9. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
10. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
11. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . , ... in a semiconductor layer. Quantum dots are small structures that ... a short laser pulse is fired at the photonic crystal, ... a change in the electromagnetic field around it. This change ... by the dot. As soon as the refractive index recovers ...
(Date:9/30/2014)... Sept. 30, 2014 Report Details ... highest potential revenues Do you want to find ... you revenue predictions for those biological drugs from ... you find financial data, R&D trends, opportunities and ... sales forecasts to 2024 at overall world market, ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Follow ... level of each type of cholesterol carrier or lipoprotein ... presence of excessive cholesterol levels in the body, especially ... condition to heart attack and other cardiovascular disorders. Cardiovascular ... therefore testing for cholesterol levels on a regular basis, ...
(Date:9/30/2014)... OriginOil Inc. (OTC/QB: OOIL), developer of ... clean up large quantities of water, announced today that ... on the launch of the company's CLEAN-FRACâ„¢ industrial grade ... partner STW Resources . , Immediately upon startup, ... (bpd) and achieved a 99.8% reduction in Turbidity on ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
... and Chemicon International, Inc. announced today ... and apply Madison-based Promegas DNA-directed, RNA interference (ddRNAi) ... division of Serologicals Corporation, will have the right ... ddRNAi-based products and reagents for life science research. ...
... so much media attention focused on the effects of ... some light on the issue. Whatever the product, there ... cheaper labor. The effects of this are hurting many ... matter what you are making, whether you manufacture low- ...
... is reducing surgery delays and controlling instrument and staff ... and trays by using a new surgical instrument management ... , ,Gundersen Lutheran operates a teaching hospital with 325 ... medical practices, community clinics, eye clinics and pharmacies. It ...
Cached Biology Technology:Offshore outsourcing affects American workers 2Offshore outsourcing affects American workers 3Gunderson Lutheran Implements Instrument Management Systems 2
(Date:10/1/2014)... Case Western Reserve University researchers hope to take a ... for an aggressive form of breast cancer in leafy ... about administering the vaccine either by eating the salad ... Nicole Steinmetz, assistant professor of biomedical engineering at Case ... project. , The Susan G. Komen breast cancer organization ...
(Date:10/1/2014)... rainforests, prairies and forests of the world can also ... according to a surprising new study led by Colorado ... , The research team analyzed 596 soil samples collected ... stunning diversity of below-ground life, most of which had ... to 16.2 percent of the organisms discovered in the ...
(Date:9/30/2014)... the University of California, San Diego, have completed the ... a method that uses the pixels in an image ... as mesh-free simulation. , The researchers, led by J.S. ... the Jacobs School of Engineering at UC San Diego, ... at the CompIMAGE,14 conference in Pittsburgh this month. Chen ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3First comprehensive meshfree numerical simulation of skeletal muscle tissue achieved 2
... Ocean explorers are puzzling out Nature,s purpose behind an astonishing ... - each perhaps a ticket-holder in life,s lottery, awaiting conditions ... The inventory and study of the hardest-to-see sea species -- ... which together underpin almost all other life on Earth -- ...
... implant that essentially melts into place, snugly fitting to the ... better devices to monitor and control seizures, and to transmit ... cord. "These implants have the potential to maximize the ... the brain. They could provide a platform for a ...
... in six will get prostate cancer during his lifetime, making ... a new partnership with Areva Med, UC researchers will investigate ... of prostate cancer tumors. In the study, UC researchers ... efficacy of a new agent targeted against a specific protein ...
Cached Biology News:Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 2Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 3Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 4Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 5Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 6Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 7Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 8Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 9Explorers census hard-to-see sea life: microbes, tiny animals key to Earth's food, carbon systems 10A brain-recording device that melts into place 2A brain-recording device that melts into place 3UC to test targeted treatment for prostate cancer 2
...
... and flexibility of the BDTM LSR, the first UV ... The BD LSR II has performance, capabilities, and ... Free up your high-performance cell sorter by moving your ... LSR II. The BD LSR II can be configured ...
... Flow Cytometer System is a full featured, two ... the C6 Flow Cytometer, CFlow Software, and a ... Cytometer System provides all the capabilities of the ... the price. The C6 Flow Cytometer System has ...
...
Biology Products: